NCT00437372 2025-05-02Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsThomas Jefferson UniversityPhase 1 Completed39 enrolled
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled